Loading …

AveXis Turns to Catalent’s Paragon for Additional Gene Therapy Manufacturing Capacity

Published on : July 16, 2019July 16, 2019 Published by : Chris Frew

Paragon Gene Therapy

Novavax Signs Strategic Partnership with Catalent’s Paragon BioServices, Secures Company Future and 100’s of Jobs

Published on : June 27, 2019June 27, 2019 Published by : Chris Frew

Novavax Signs Strategic Partnership with Catalent’s Paragon BioServices, Secures Company Future and 100’s of Jobs June 27, 2019 Montgomery County Maryland’s Novavax has had a rocky road to say the least, and the latest failed Phase III RSV trial earlier this year put the company in a difficult position to recover from. Aside from the [….]

Paragon BioServices gets $1.2B Acquisition Deal by Catalent after launch of New Gene Therapy Manufacturing Facility

Published on : April 15, 2019April 17, 2019 Published by : Chris Frew

Paragon BioServices gets $1.2B Acquisition Deal by Catalent after launch of New Gene Therapy Manufacturing Facility April 15, 2019 Paragon BioServices, the home-grown Maryland biotech company that started in a Baltimore incubator 30 years ago, has grown to more than 400 employees and is two weeks away from beginning production in a brand new 150,000 [….]